PFIZER Stock Quote

$35.995 arrow  Change: 0.04 %Chge: 0.11% Vol: 659,157
End Of Day Prices
High: 36.17 | Low: 35.92 | Open: 35.95 | Close: 35.995
52 Wk High: 36.17 | 52 Wk Low: 29.855 | Todays Pivot: 36.03
Sector: Healthcare and Pharmaceuticals add stock to watch list

Pfizer Company Profile

Pfizer, Inc. (PFE) is a major producer of pharmaceutical products. This research-based company continues to stay at the top of the charts for sales worldwide. A few of the company's top products include Lipitor, Diflucan, Zithromax and Viagra. The company also has a line of animal healthcare products. In 2009 Pfizer announced that they would join forces with another large pharmaceutical company, GlaxoSmithKline to start a new HIV company that

» Read More About Pfizer

PFE Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Community Health Sys Newco 19.41 green arrow 111,219
Celgene 138.23 red arrow 192,344
Bard C R 97.75 green arrow 882,500
Bio Rad Labs 156.35 red arrow 6,771
Pharmaceutical Prod Dev 28.52 green arrow 70,931
Celgene 79.11 green arrow 456,528
United Therapeutics Del 150.26 red arrow 22,289
Boston Scientific 23.42 red arrow 355,629

Above is a small selection of related companies to Pfizer which compete alongside PFE within the Healthcare and Pharmaceuticals sector. To see more related companies to PFE, view our stock market today information page.

Online News For Pfizer

Can Pfizer (PFE) Prove to be an Apt Value Investment?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when ...

Pfizer’s Revenues in Review: PFE’s Quarterly Performance

Pfizer (PFE) reported revenues of ~$12.9 billion for 2Q17, which was ~2% lower than its revenues of ~$13.2 billion in 2Q16. The company missed Wall Street analysts’ 2Q17 estimate for revenues, reporting revenues of ~$12.9 billion for 2Q17, compared with ...

Pfizer Inc (NYSE:PFE) Institutional Investor Sentiment Analysis

They expect $0.64 EPS, up 4.92% or $0.03 from last year's $0.61 per share. The company's P/E ratio is 25.93 and market capitalization is 210.83B. This means that the stock's daily price swings have been more extreme in recent times compared to the past.

Pfizer, Inc. (PFE) Holdings Trimmed by Mutual of America Capital Management LLC

Pfizer Inc. (NYSE:PFE) has declined 2.76% since September 20, 2016 and is downtrending. The company had a trading volume of 2,421,061 shares. Chicago Equity Lc holds 0.98% in Pfizer Inc. Farmers & Merchants Investments Inc. raised its holdings in shares of ...

Morgan Stanley Upgrades Rating On Pfizer, Inc. (PFE)

The company has market cap of $213.49 billion. The stock has an average rating of "Hold" and an average target price of $38.04. About 110 shares traded. Vanguard Group Inc. increased its holdings in shares of Pfizer by 2.3% in the second quarter.

Want To Add This Quote To Your Site?

With our stock widgets you can add a Pfizer quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for PFE to choose from. Visit here to build your stock quote widget »